Trial Watch: Lenalidomide-based immunochemotherapy

Lenalidomide is a synthetic derivative of thalidomide currently approved by the US Food and Drug Administration for use in patients affected by multiple myeloma (in combination with dexamethasone) and low or intermediate-1 risk myelodysplastic syndromes that harbor 5q cytogenetic abnormalities. For...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Semeraro, Michaela, Vacchelli, Erika, Eggermont, Alexander, Galon, Jerome, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Materialtyp: Artigo
Språk:Inglês
Publicerad: Landes Bioscience 2013
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3897503/
https://ncbi.nlm.nih.gov/pubmed/24482747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.26494
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk